Ironshore Pharmaceuticals & Development, Inc.
USPTO PatentsView assignee record - 22 granted patents across 2 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Ironshore ranks #13,502 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 2 technology areas.
- #13,502
- of 49,997 US assignees by volume
- 30th percentile
- by Innovation Score (29.2/100)
- 16.7
- avg claims per patent
- -60%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13502 · Foreign Corporation #13,502 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 22 grants
- MID-PACK #13,502/49,997
- PHOTO-FINISH Interwell Norway AS
- CPC-NARROW A61K · 2 areas
- INNOV-THIN 29.2/100
- CLAIMS-RICH 16.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -60% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Interwell Norway AS (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ironshore’s 29.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ironshore
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ironshore Pharmaceut… · this assignee 29
Ironshore Pharmaceut… · this assignee
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ironshore's Innovation Score is 29.2/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ironshore?
Each dot is one of Ironshore’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ironshore’s own 16.7 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Ironshore's grants concentrate
Ironshore Pharmaceuticals & Development, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2018. By volume, Ironshore sits between Interwell Norway AS and Jinko Solar (HAINING) Co., Ltd..
Ironshore's three-year grant acceleration
Ironshore Pharmaceuticals & Development, Inc. shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Ironshore's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Interwell Norway…
Interwell Norway AS
22 patents
- Invatec S P A
Invatec S.P.A
22 patents
- Invecas
Invecas, Inc.
22 patents
- Iogen Energy
Iogen Energy Corporation
22 patents
- Ivax Pharmaceutic…
Ivax Pharmaceuticals Ireland
22 patents
- Jakks Pacific
Jakks Pacific Inc.
22 patents
- Japan Technologic…
Japan Technological Research Association OF Artificial Photosynthetic Chemical Process
22 patents
- Jinko Solar (Hain…
Jinko Solar (HAINING) Co., Ltd.
22 patents
- Ironshore Pharmac… ◀
Ironshore Pharmaceuticals & Development, Inc.
22 patents
What this shows Ironshore holds 22 patents at rank #13,501, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ironshore
By rank, the assignees closest to #13,501 in granted patent volume.
- Interwell Norway AS #13,497 · 22 patents
- Invatec S.P.A #13,498 · 22 patents
- Invecas, Inc. #13,499 · 22 patents
- Iogen Energy Corporation #13,500 · 22 patents
- Ivax Pharmaceuticals Ireland #13,502 · 22 patents
- Jakks Pacific Inc. #13,503 · 22 patents
- Japan Technological Research Association OF Artificial Photosynthetic Chemical Process #13,504 · 22 patents
- Jinko Solar (HAINING) Co., Ltd. #13,505 · 22 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Ironshore's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Ironshore's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 30th percentile higher than 30% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 22.7% |
| 2016 | 4 | 18.2% |
| 2017 | 2 | 9.1% |
| 2018 | 1 | 4.5% |
| 2019 | 3 | 13.6% |
| 2020 | 1 | 4.5% |
| 2021 | 2 | 9.1% |
| 2022 | 2 | 9.1% |
| 2024 | 1 | 4.5% |
| 2025partial year | 1 | 4.5% |
Which technologies does Ironshore Pharmaceuticals & Development, Inc. patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ironshore Pharmaceuticals & Development, Inc.'s patent record in context - here's where to go next.
- Ironshore Pharmaceuticals & Development, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #13,502 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ironshore Pharmaceuticals & Development, Inc. against Interwell Norway AS, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.